glp-1 and macular degeneration Agonists May Lower Risk of GLP-1 Receptor Agonists and the

THIS YEAR, at the American College of Rheumatology (ACR) Convergence 2025, a dedicated session explored whether glucagon-like peptide-1...

BackgroundReal-world data on liraglutide for pediatric obesity is limited, especially in public healthcare systems of low- and middle-income countries.Object...

Berberine-induced glucagon-like peptide-1 and its mechanism for controlling type 2 diabetes mellitus: a comprehensive pathway review

The year delivered progress across clinical evidence, policy, and changing market dimensions, reinforcing obesity as a chronic disease requiring structured, long-term management

And, how do you know how much you are getting

Bloating can be a side effect of semaglutide and other GLP-1 medications